Ralph Snyderman, MD, is Chancellor Emeritus, Duke University, James B. Duke Professor of Medicine, and Director of the Center for Research in Personalized Health Care at the Duke University School of Medicine. He previously served as Chancellor for Health Affairs at Duke University and as the founding President and CEO of the Duke University Health System; Dean of the School of Medicine at Duke University; Chair of the Association of American Medical Colleges; Senior Vice President, Medical Research and Development, Genentech, Inc.; Director, Laboratory of Immune Effector Function, Howard Hughes Medical Institute; Chief, Division of Rheumatology and Immunology at Duke; and Senior Investigator, National Institutes of Health. Dr. Snyderman has received numerous honors, including the Personalized Medicine World Conference Pioneer Award (2016), the North Carolina Life Sciences Leadership Award (2014), the Association of American Medical Colleges David E. Rogers Award (2012), the Industr
Dr. Snyderman outlines the advances made in race and gender equality. He describes efforts within the Duke University Medical System, and also partnerships with local organizations. He provides brief biographies of staff who were at the forefront of ensuring equity and diversity.
One of the discrete institutional innovations of Dr. Snyderman’s tenure as Chancellor was the creation of the Duke Clinical Research Institute (DCRI). Looked down upon by top-tier medical schools and academic medical centers, clinical research and trials nevertheless seemed to Dr. Snyderman an inherently important function of academic medicine and one bound to grow in importance and prestige. This prediction proved true as Duke became the leader in academic clinical research and garnered multiple NIH and commercial grants. The DCRI grew in importance and prestige with the new appreciation of translational research. Other institutions followed Duke’s lead.